San Francisco Bay Area biotech stories.
Friday, September 2, 2011
FDA to decide on Vivus erectile dysfunction drug by end of April
Federal regulators accepted Vivus Inc.’s potential treatment for erectile dysfunction, the Mountain View company said Thursday, moving the drug one step closer to approval by the end of April.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)